Charles River Laboratories International Inc’s recent filing unveils that its Chairman, President and CEO FOSTER JAMES C acquired Company’s shares for reported $1.0 million on Feb 20 ’25. In the deal valued at $165.01 per share,6,075 shares were bought. As a result of this transaction, FOSTER JAMES C now holds 183,639 shares worth roughly $21.19 million.
Then, Girshick Birgit bought 1,514 shares, generating $249,250 in total proceeds. Upon buying the shares at $164.63, the Corporate Executive VP & COO now owns 55,058 shares.
Before that, LaPlume Joseph W sold 4,400 shares. Charles River Laboratories International Inc shares valued at $715,000 were divested by the EVP, Corp Strategy & Develop at a price of $162.50 per share. As a result of the transaction, LaPlume Joseph W now holds 20,013 shares, worth roughly $2.31 million.
Goldman downgraded its Charles River Laboratories International Inc [CRL] rating to a Neutral from a a Buy in a research note published on March 21, 2025; the price target was decreased to $170 from $190. A number of analysts have revised their coverage, including Citigroup’s analysts, who increased its forecast for the stock in early March from “a Sell” to “a Neutral”. Redburn Atlantic also remained covering CRL and has increased its forecast on March 03, 2025 with a “Neutral” recommendation from previously “Sell” rating. William Blair revised its rating on January 22, 2025. It rated CRL as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of CRL
On Tuesday, Charles River Laboratories International Inc [NYSE:CRL] saw its stock fall -3.37% to $115.41. Over the last five days, the stock has lost -1.60%. Charles River Laboratories International Inc shares have fallen nearly -37.48% since the year began. Nevertheless, the stocks have fallen -49.80% over the past one year. While a 52-week high of $254.15 was reached on 01/07/25, a 52-week low of $91.86 was recorded on 04/11/25. SMA at 50 days reached $142.56, while 200 days put it at $179.63.
Levels Of Support And Resistance For CRL Stock
The 24-hour chart illustrates a support level at 112.86, which if violated will result in even more drops to 110.30. On the upside, there is a resistance level at 118.99. A further resistance level may holdings at 122.57. The Relative Strength Index (RSI) on the 14-day chart is 41.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.88, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 29.08%. Stochastics %K at 81.64% indicates the stock is a selling.
